Effects of Levothyroxine on Endothelial Function of Patients With Subclinical Hypothyroidism
Launched by ISFAHAN UNIVERSITY OF MEDICAL SCIENCES · Mar 17, 2014
Trial Information
Current as of June 17, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age 18 to 65
- • confirmed subclinical hypothyroidism
- Exclusion Criteria:
- • receiving of other treatments for hypothyroidism
- • patients with other major medical disorders
- • smoking
- • hyperlipidemia
- • obesity
About Isfahan University Of Medical Sciences
Isfahan University of Medical Sciences is a leading academic institution in Iran, dedicated to advancing healthcare through innovative research and education. With a strong emphasis on clinical trials, the university plays a critical role in developing new medical treatments and improving patient outcomes. Its research initiatives are supported by a diverse team of professionals, including physicians, scientists, and healthcare practitioners, who collaborate to address pressing health challenges. The university is committed to adhering to the highest ethical standards and regulatory guidelines, ensuring the integrity and reliability of its clinical research endeavors. Through its comprehensive approach, Isfahan University of Medical Sciences aims to contribute significantly to the global medical community and enhance public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Isfahan, , Iran, Islamic Republic Of
Patients applied
Trial Officials
Nasmi Niknam, M.D.
Principal Investigator
Isfahan University of Medical Sciences
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials